Metabolomics reveals differential metabolic adjustments of normal and overweight subjects during overfeeding

Metabolomics

Volumn 11, Issue 4, 2015, Pages 920-938

  Morio, Beatrice ^a,b   Comte, Blandine ^a,b   Martin, Jean François ^a,b,c   Chanseaume, Emilie ^a,b   Alligier, Maud ^e,f   Junot, Christophe ^d   Lyan, Bernard ^a,b,c   Boirie, Yves ^a,b   Vidal, Hubert ^e,f   Laville, Martine ^e,f   Pujos Guillot, Estelle ^a,b,c   Sébédio, Jean Louis ^a,b,c  

^a CRNH AUVERGNE   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c INRA and University of Auvergne   (France)

^d DIF   (France)

^e CarMeN   (France)

^f CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Lipid enriched overnutrition; Nutritional metabolomics; UPLC MS; Urinary metabolic trajectories; Weight gain

Indexed keywords

CHOLESTEROL; FATTY ACID; GLYCEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; EATING HABIT; ELECTROSPRAY MASS SPECTROMETRY; FATTY ACID OXIDATION; FOOD COMPOSITION; FOOD PROCESSING; HUMAN; INFLAMMATION; LIQUID CHROMATOGRAPHY; MALE; METABOLOMICS; OBESITY; OVERNUTRITION; PHENOTYPE; WEIGHT GAIN;

EID: 84931565023     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-014-0750-y     Document Type: Article

References (56)

1. Adams, S. H., Hoppel, C. L., Lok, K. H., Zhao, L., Wong, S. W., Minkler, P. E., et al. (2009). Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. Journal of Nutrition,139(6), 1073–1081. doi:10.3945/jn.108.103754.
2. Alligier, M., Gabert, L., Meugnier, E., Lambert-Porcheron, S., Chanseaume, E., Pilleul, F., et al. (2013). Visceral fat accumulation during lipid overfeeding is related to subcutaneous adipose tissue characteristics in healthy men. Journal of Clinical Endocrinology and Metabolism,98(2), 802–810. doi:10.1210/jc.2012-3289.
3. Alligier, M., Meugnier, E., Debard, C., Lambert-Porcheron, S., Chanseaume, E., Sothier, M., et al. (2012). Subcutaneous adipose tissue remodeling during the initial phase of weight gain induced by overfeeding in humans. Journal of Clinical Endocrinology and Metabolism,97(2), E183–E192. doi:10.1210/jc.2011-2314.
4. Alnouti, Y., Csanaky, I. L., & Klaassen, C. D. (2008). Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences,873(2), 209–217. doi:10.1016/j.jchromb.2008.08.018.
5. Altmaier, E., Ramsay, S. L., Graber, A., Mewes, H. W., Weinberger, K. M., & Suhre, K. (2008). Bioinformatics analysis of targeted metabolomics–uncovering old and new tales of diabetic mice under medication. Endocrinology,149(7), 3478–3489. doi:10.1210/en.2007-1747.
6. Benton, H. P., Wong, D. M., Trauger, S. A., & Siuzdak, G. (2008). XCMS2: Processing tandem mass spectrometry data for metabolite identification and structural characterization. Analytical Chemistry,80(16), 6382–6389. doi:10.1021/ac800795f.
7. Caraux, G., & Pinloche, S. (2005). PermutMatrix: A graphical environment to arrange gene expression profiles in optimal linear order. Bioinformatics,21(7), 1280–1281. doi:10.1093/bioinformatics/bti141.
8. D’Arrigo, P., & Servi, S. (2010). Synthesis of lysophospholipids. Molecules,15(3), 1354–1377. doi:10.3390/molecules15031354.
9. Dettmer, K., Aronov, P. A., & Hammock, B. D. (2007). Mass spectrometry-based metabolomics. Mass Spectrometry Reviews,26(1), 51–78. doi:10.1002/mas.20108.
10. Duranti, G., Boenzi, S., Rizzo, C., Rava, L., Di Ciommo, V., Carrozzo, R., et al. (2008). Urine acylcarnitine analysis by ESI-MS/MS: A new tool for the diagnosis of peroxisomal biogenesis disorders. Clinica Chimica Acta,398(1–2), 86–89. doi:10.1016/j.cca.2008.08.018.
11. Eisenreich, W., & Bacher, A. (2007). Advances of high-resolution NMR techniques in the structural and metabolic analysis of plant biochemistry. Phytochemistry,68(22–24), 2799–2815. doi:10.1016/j.phytochem.2007.09.028.
12. Franceschi, P., Masuero, D., Vrhovsek, U., Mattivi, F., & Wehrens, R. (2012). A benchmark spike-in data set for biomarker identification in metabolomics. Journal of Chemometrics,26(1–2), 16–24. doi:10.1002/cem.1420.
13. Galgani, J. E., Moro, C., & Ravussin, E. (2008). Metabolic flexibility and insulin resistance. The American Journal of Physiology—Endocrinology and Metabolism,295(5), E1009–E1017. doi:10.1152/ajpendo.90558.2008.
14. Gibney, M. J., Walsh, M., Brennan, L., Roche, H. M., German, B., & van Ommen, B. (2005). Metabolomics in human nutrition: Opportunities and challenges. American Journal of Clinical Nutrition,82(3), 497–503.
15. Ha, C. Y., Kim, J. Y., Paik, J. K., Kim, O. Y., Paik, Y. H., Lee, E. J., & Lee, J. H. (2012). The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes. Clinical Endocrinology (Oxford),76(5), 674–682. doi:10.1111/j.1365-2265.2011.04244.x.
16. Hanhineva, K., Barri, T., Kolehmainen, M., Pekkinen, J., Pihlajamaki, J., Vesterbacka, A., et al. (2013). Comparative nontargeted profiling of metabolic changes in tissues and biofluids in high-fat diet-fed Ossabaw pig. Journal of Proteome Research,12(9), 3980–3992. doi:10.1021/pr400257d.
17. Huang, L. S., Hung, N. D., Sok, D. E., & Kim, M. R. (2010). Lysophosphatidylcholine containing docosahexaenoic acid at the sn-1 position is anti-inflammatory. Lipids,45(3), 225–236. doi:10.1007/s11745-010-3392-5.
18. Hung, N. D., Kim, M. R., & Sok, D. E. (2009). Anti-inflammatory action of arachidonoyl lysophosphatidylcholine or 15-hydroperoxy derivative in zymosan A-induced peritonitis. Prostaglandins & Other Lipid Mediators,90(3–4), 105–111. doi:10.1016/j.prostaglandins.2009.10.001.
19. Hung, N. D., Kim, M. R., & Sok, D. E. (2011). 2-Polyunsaturated acyl lysophosphatidylethanolamine attenuates inflammatory response in zymosan A-induced peritonitis in mice. Lipids,46(10), 893–906. doi:10.1007/s11745-011-3589-2.
20. Hung, N. D., Sok, D. E., & Kim, M. R. (2012). Prevention of 1-palmitoyl lysophosphatidylcholine-induced inflammation by polyunsaturated acyl lysophosphatidylcholine. Inflammation Research,61(5), 473–483. doi:10.1007/s00011-012-0434-x.
21. Idle, J. R., & Gonzalez, F. J. (2007). Metabolomics. Cell Metabolism,6(5), 348–351. doi:10.1016/j.cmet.2007.10.005.
22. Joyce, S. A., & Gahan, C. G. (2014). The gut microbiota and the metabolic health of the host. Current Opinion in Gastroenterology,30(2), 120–127. doi:10.1097/MOG.0000000000000039.
23. Kaess, B. M., Pedley, A., Massaro, J. M., Murabito, J., Hoffmann, U., & Fox, C. S. (2012). The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk. Diabetologia,55(10), 2622–2630. doi:10.1007/s00125-012-2639-5.
24. Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000). Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. Journal of Clinical Endocrinology and Metabolism,85(7), 2402–2410.
25. Kenny, L. C., Black, M. A., Poston, L., Taylor, R., Myers, J. E., Baker, P. N., et al. (2014). Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: The Screening for Pregnancy Endpoints (SCOPE) international cohort study. Hypertension,64(3), 644–652. doi:10.1161/HYPERTENSIONAHA.114.03578.
26. Kim, J. Y., Park, J. Y., Kim, O. Y., Ham, B. M., Kim, H. J., Kwon, D. Y., et al. (2010). Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). Journal of Proteome Research,9(9), 4368–4375. doi:10.1021/pr100101p.
27. Kootte, R. S., Vrieze, A., Holleman, F., Dallinga-Thie, G. M., Zoetendal, E. G., de Vos, W. M., et al. (2012). The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes, Obesity & Metabolism,14(2), 112–120. doi:10.1111/j.14631326.2011.01483.x.
28. Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., et al. (2008). Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metabolism,7(1), 45–56. doi:10.1016/j.cmet.2007.10.013.
29. Lefebvre, P., Cariou, B., Lien, F., Kuipers, F., & Staels, B. (2009). Role of bile acids and bile acid receptors in metabolic regulation. Physiological Reviews,89(1), 147–191. doi:10.1152/physrev.00010.2008.
30. Libert, R., Van Hoof, F., Thillaye, M., Vincent, M. F., Nassogne, M. C., de Hoffmann, E., & Schanck, A. (2000). Identification of undescribed medium-chain acylcarnitines present in urine of patients with propionic and methylmalonic acidemias. Clinica Chimica Acta,295(1–2), 87–96.
31. Meugnier, E., Bossu, C., Oliel, M., Jeanne, S., Michaut, A., Sothier, M., et al. (2007). Changes in gene expression in skeletal muscle in response to fat overfeeding in lean men. Obesity (Silver Spring),15(11), 2583–2594. doi:10.1038/oby.2007.310.
32. Mihalik, S. J., Goodpaster, B. H., Kelley, D. E., Chace, D. H., Vockley, J., Toledo, F. G., & DeLany, J. P. (2010). Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity (Silver Spring),18(9), 1695–1700. doi:10.1038/oby.2009.510.
33. Mihalik, S. J., Michaliszyn, S. F., de las Heras, J., Bacha, F., Lee, S., Chace, D. H., et al. (2012). Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation. Diabetes Care,35(3), 605–611. doi:10.2337/DC11-1577.
34. Moco, S., Bino, R. J., De Vos, R. C. H., & Vervoort, J. (2007). Metabolomics technologies and metabolite identification. TrAC Trends in Analytical Chemistry,26(9), 855–866. doi:10.1016/j.trac.2007.08.003.
35. Momken, I., Stevens, L., Bergouignan, A., Desplanches, D., Rudwill, F., Chery, I., et al. (2011). Resveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the rat. FASEB J.,25(10), 3646–3660. doi:10.1096/fj.10-177295.
36. Nazare, J. A., Normand, S., Oste Triantafyllou, A., Brac de la Perriere, A., Desage, M., & Laville, M. (2009). Modulation of the postprandial phase by beta-glucan in overweight subjects: Effects on glucose and insulin kinetics. Molecular Nutrition & Food Research,53(3), 361–369. doi:10.1002/mnfr.200800023.
37. Newgard, C. B. (2012). Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metabolism,15(5), 606–614. doi:10.1016/j.cmet.2012.01.024.
38. Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., et al. (2009). A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metabolism,9(4), 311–326. doi:10.1016/j.cmet.2009.02.002.
39. Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999). ‘Metabonomics’: Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica,29(11), 1181–1189. doi:10.1080/004982599238047.
40. Nieuwdorp, M., Gilijamse, P. W., Pai, N., & Kaplan, L. M. (2014). Role of the microbiome in energy regulation and metabolism. Gastroenterology,146(6), 1525–1533. doi:10.1053/j.gastro.2014.02.008.
41. Pan, Z., & Raftery, D. (2007). Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Analytical and Bioanalytical Chemistry,387(2), 525–527. doi:10.1007/s00216-006-0687-8.
42. Pereira, H., Martin, J. F., Joly, C., Sebedio, J. L., & Pujos-Guillot, E. (2010). Development and validation of a UPLC/MS method for a nutritional metabolomic study of human plasma. Metabolomics,6(2), 207–218. doi:10.1007/s11306-009-0188-9.
43. Pietilainen, K. H., Sysi-Aho, M., Rissanen, A., Seppanen-Laakso, T., Yki-Jarvinen, H., Kaprio, J., & Oresic, M. (2007). Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects–a monozygotic twin study. PLoS One,2(2), e218. doi:10.1371/journal.pone.0000218.
44. Popkin, B. M. (2011). Is the obesity epidemic a national security issue around the globe? Current opinion in Endocrinology, Diabetes, and Obesity,18(5), 328–331. doi:10.1097/MED.0b013e3283471c74.
45. Rimbert, V., Boirie, Y., Bedu, M., Hocquette, J. F., Ritz, P., & Morio, B. (2004). Muscle fat oxidative capacity is not impaired by age but by physical inactivity: Association with insulin sensitivity. FASEB J,18(6), 737–739. doi:10.1096/fj.03-1104fje.
46. Rubio-Aliaga, I., Roos, Bd, Sailer, M., McLoughlin, G. A., Boekschoten, M. V., van Erk, M., et al. (2011). Alterations in hepatic one-carbon metabolism and related pathways following a high-fat dietary intervention. Physiological Genomics,43(8), 408–416. doi:10.1152/physiolgenomics.00179.2010.
47. Saccenti, E., Hoefsloot, H. C. J., Smilde, A. K., Westerhuis, J. A., & Hendriks, M. M. W. B. (2014). Reflections on univariate and multivariate analysis of metabolomics data. Metabolomics,10, 361–374. doi:10.1007/s11306-013-0598-6.
48. Sevastou, I., Kaffe, E., Mouratis, M. A., & Aidinis, V. (2013). Lysoglycerophospholipids in chronic inflammatory disorders: The PLA(2)/LPC and ATX/LPA axes. Biochimica et Biophysica Acta,1831(1), 42–60. doi:10.1016/j.bbalip.2012.07.019.
49. Smith, C. A., Want, E. J., O’Maille, G., Abagyan, R., & Siuzdak, G. (2006). XCMS: Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Analytical Chemistry,78(3), 779–787. doi:10.1021/ac051437y.
50. Steiber, A., Kerner, J., & Hoppel, C. L. (2004). Carnitine: A nutritional, biosynthetic, and functional perspective. Molecular Aspects of Medicine,25(5–6), 455–473. doi:10.1016/j.mam.2004.06.006.
51. Sumner, L. W., Amberg, A., Barrett, A., Beale, M. H., Beger, R., Daykin, C. A., et al. (2007). Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics,3(9), 211–221.
52. Taylor, D. R., Alaghband-Zadeh, J., Cross, G. F., Omar, S., le Roux, C. W., & Vincent, R. P. (2014). Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2. PLoS One,9(4), e93540. doi:10.1371/journal.pone.0093540.
53. Vrieze, A., Out, C., Fuentes, S., Jonker, L., Reuling, I., Kootte, R. S., et al. (2014). Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. Journal of Hepatology,60(4), 824–831. doi:10.1016/j.jhep.2013.11.034.
54. Wang, C., Feng, R. N., Sun, D. J., Li, Y., Bi, X. X., & Sun, C. H. (2011). Metabolic profiling of urine in young obese men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC/Q-TOF MS). Journal of Chromatography B,879(27), 2871–2876. doi:10.1016/j.jchromb.2011.08.014.
55. Wishart, D. S. (2007). Current progress in computational metabolomics. Briefings in Bioinformatics,8(5), 279–293. doi:10.1093/bib/bbm030.
56. Zeng, M., Liang, Y., Li, H., Wang, M., Wang, B., Chen, X., et al. (2010). Plasma metabolic fingerprinting of childhood obesity by GC/MS in conjunction with multivariate statistical analysis. Journal of Pharmaceutical and Biomedical Analysis,52(2), 265–272. doi:10.1016/j.jpba.2010.01.002.